Periodic Reporting for period 3 - SAPHELY (Self-amplified photonic biosensing platform for microRNA-based early diagnosis of diseases)

In today’s point-of-care (POC) market segment, there is an ever-increasing demand for novel and more efficient devices for the early diagnosis of diseases, with a special interest in cancer. According to statistics from the World Health Organization (WHO), each year...